What is the differential diagnosis for an 86-year-old woman presenting with a vulvar lump?

Differential Diagnosis for Vulvar Lump in an 86-Year-Old Woman

The most critical diagnosis to exclude in an 86-year-old woman with a vulvar lump is squamous cell carcinoma, which accounts for 90% of vulvar cancers and predominantly affects older women, with the labia majora being the most common site. 1, 2

Malignant Etiologies (Priority Considerations)

Squamous Cell Carcinoma (Most Common - 90% of vulvar cancers)

• Risk factors particularly relevant at age 86: Advanced age is itself a major risk factor, chronic HPV infection (up to 69% of cases), tobacco use, chronic vulvar inflammation, and immunocompromised states 2
• Location: Majority originate in the labia majora 2
• Prognosis: 5-year survival is 86% for vulvar-confined disease but drops to 57% with regional lymph node metastases and 17% with distant metastases 2, 1
• Critical action: Punch biopsy of any suspicious vulvar lesion is mandatory, ensuring inclusion of underlying stroma while avoiding necrotic areas 2

Other Malignant Histologies (Rare but Important)

• Melanoma - Second most common after SCC 1
• Extramammary Paget disease 1
• Bartholin gland adenocarcinoma 1
• Basal cell carcinoma 1
• Adenocarcinoma of mammary gland type (AMGT) - Extremely rare, presents as nodular lesions, requires immunohistochemistry (GATA3, ER, PR, GCDFP-15 positive) 3, 4
• Sarcomas including Ewing sarcoma - Exceedingly rare but reported in postmenopausal women 5

Benign Etiologies

Common Benign Lesions

• Bartholin gland cyst/abscess - Often misdiagnosed preoperatively as other vulvar masses 6
• Vulvar leiomyoma - Rare (0.03% of gynecologic neoplasms), presents as well-circumscribed, painless, solitary growths; can occur at any age including elderly 6
• Lymphangioma circumscriptum - Benign lymphatic malformation presenting as grouped vesicles, exceptionally rare on vulva 7

Immediate Diagnostic Approach

The algorithmic workup should proceed as follows:

1. Clinical examination specifics to document:

   • Lesion size and exact location relative to midline (affects surgical approach)
   • Relationship to adjacent structures (urethra, vagina, anus)
   • Presence of multifocal disease
   • Palpation of inguinofemoral lymph nodes (though high false-negative rate) 2

2. Mandatory tissue diagnosis:

   • Punch biopsy of ALL suspicious vulvar lesions - This is non-negotiable 2
   • Include underlying stroma, avoid necrotic areas
   • If malignancy confirmed, assess depth of stromal invasion and lymphovascular space invasion

3. If malignancy confirmed on biopsy:

   • Imaging for staging: CT chest/abdomen/pelvis or FDG-PET/CT for neck/chest/abdomen/pelvis/groin 8
   • Inguinofemoral lymph node status is the most important prognostic factor 2

Critical Pitfalls to Avoid

• Never assume a vulvar lump is benign based on appearance alone - Even "cyst-like" lesions can be malignant 6
• Do not delay biopsy - At age 86, the probability of malignancy is significantly elevated given age as an independent risk factor
• Clinical palpation of lymph nodes is unreliable - Has high false-negative rate; if cancer confirmed, formal lymph node assessment required 2
• Avoid superficial biopsies - Must include stroma for accurate depth of invasion assessment, which determines treatment 2

Given the patient's age and the high mortality associated with delayed diagnosis of vulvar cancer (5-year survival drops from 86% to 17% with metastatic disease), immediate punch biopsy is the definitive next step. 2, 1